Azathioprine, Used to Treat IBD, Linked to Skin Cancer, Researchers Warn

Azathioprine, Used to Treat IBD, Linked to Skin Cancer, Researchers Warn
Azathioprine, used to treat inflammatory bowel disease, arthritis, and other conditions, has been linked to the development of skin cancer in a group of patients. In the study "The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature," researchers recommend that sun protection, skin surveillance, and early identification and removal of lesions be part of the management of patients on azathioprine. Cutaneous squamous cell carcinoma (cSCC) is a common form of skin cancer, with about 1 million new cases reported in the U.S. every year. Despite its high incidence, scientists are still in the dark regarding
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *